The Oxford Handbook Of Global Drug History

"This essay reveals how a global "New Drug History" has evolved over the past three decades, along with its latest thematic trends and possible next directions. Scholars have long studied drugs, but only in the 1990s did serious archival and global study of what are now illicit drugs emerge, largely from the influence of the anthropology of drugs on history. A series of key interdisciplinary influences are now in play beyond anthropology, among them, commodity and consumption studies, sociology, medical history, cultural studies, and transnational history. Scholars connect drugs and their changing political or cultural status to larger contexts and epochal events such as wars, empires, capitalism, modernization, or globalizing processes. As the field expands in scope, it may shift deeper into non-western perspectives, a fluid historical definition of drugs; environmental concerns; and research on cannabis and opiates sparked by their current transformations or crises"--

"This essay reveals how a global "New Drug History" has evolved over the past three decades, along with its latest thematic trends and possible next directions. Scholars have long studied drugs, but only in the 1990s did serious archival and global study of what are now illicit drugs emerge, largely from the influence of the anthropology of drugs on history. A series of key interdisciplinary influences are now in play beyond anthropology, among them, commodity and consumption studies, sociology, medical history, cultural studies, and transnational history. Scholars connect drugs and their changing political or cultural status to larger contexts and epochal events such as wars, empires, capitalism, modernization, or globalizing processes. As the field expands in scope, it may shift deeper into non-western perspectives, a fluid historical definition of drugs; environmental concerns; and research on cannabis and opiates sparked by their current transformations or crises"--

This handbook explores organized crime, which it divides into two main concepts and types: the first is a set of stable organizations illegal per se or whose members systematically engage in crime, and the second is a set of serious criminal activities that are typically carried out for monetary gain.

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summarizes the latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.

While the success of national and international law enforcement cooperation to suppress organized crime means that stable, large-scale criminal organizations like the Cosa Nostra or the Japanese Yakuza have seen their power reduced, organized crime remains a concern for many governments. Economic globalization and the easing of restrictions on exchanges across borders now provide ample opportunity for money-making activities in illegal markets. Policies designed to stop illegal market flows often shift these activities to new places or create new problems, as the U.S.- led war on drugs spread production and trafficking to a number South and Central American countries. The Oxford Handbook of Organized Crime provides informed, authoritative, and comprehensive overviews of these issues and other principal forms of organized crime, as well as the type and effectiveness of efforts to prevent and control them. Leading scholars from criminology, law, sociology, history, and political science discuss the key concepts, history, and methods of organized crime; the major actors and interactions involved in it; the markets and activities frequently associated with organized crime; and the policies designed to combat it. Individual chapters on criminal organizations and specific activities or markets comprise the heart of the volume. The chapters on actors provide the history, analyze the structure and activities, and assess the strength and future prospects of each organization. Articles on particular markets address the patterns of activity, identify the most affected regions, and where possible provide estimated revenues, discuss factors promoting the activity, and disclose information on the victims and harms caused. The Oxford Handbook of Organized Crime delivers a systematic, high-quality, and truly global approach to the topic and with it a more complete understanding of organized crime in its many forms for researchers, government officials, and policymakers.

Substance use and substance use disorders (SUDs) have been documented in a number of cultures since the beginnings of recorded time and represent major societal concerns in the present day. The Oxford Handbook of Substance Use and Substance Use Disorders provides comprehensive reviews of key areas of inquiry into the fundamental nature of substance use and SUDs, their features, causes, consequences, course, treatment, and prevention. It is clear that understanding these various aspects of substance use and SUDs requires a multidisciplinary perspective that considers the pharmacology of drugs of abuse, genetic variation in these acute and chronic effects, and psychological processes in the context of the interpersonal and cultural contexts. Comprising two volumes, this Handbook also highlights a range of opportunities and challenges facing those interested in the basic understanding of the nature of these phenomena and novel approaches to assess, prevent, and treat these conditions with the goal of reducing the enormous burden these problems place on our global society. Chapters in Volume 1 cover the historical and cultural contexts of substance use and its consequences, its epidemiology and course, etiological processes from the perspective of neuropharmacology, genetics, personality, development, motivation, and the interpersonal and larger social environment. Chapters in Volume 2 cover major health and social consequences of substance involvement, psychiatric comorbidity, assessment, and interventions. Each chapter highlights key issues in the respective topic area and raises unanswered questions for future research. All chapters are authored by leading scholars in each topic. The level of coverage is sufficiently deep to be of value to both trainees and established scientists and clinicians interested in an evidenced-based approach.

As globalization explodes, so has international business scholarship. This second edition of the Oxford Handbook of International Business synthesises all the relevant literature of the last 40 years in 28 original chapters by the world's most distinguished scholars. Reflecting the changes and development in the field since the first edition this new edition has a changed structure, all the chapters have been updated to take account of the latest scholarship, and five new chapters freshly written. The Handbook is divided into six major sections, providing comprehensive coverage of the following areas: · History and Theory of the Multinational Enterprise · The Political and Regulatory Environment · Strategy and International Management · Managing the MNE · Area Studies · Methodological Issues These state of the art literature reviews will be invaluable references for students in business schools, social sciences, law, and area studies.

Written by biomedical scientists and clinicians, with the purpose of disseminating the fundamental scientific principles that underpin medicine, this new edition of the Oxford Handbook of Medical Sciences provides a clear, easily digestible account of basic cell physiology and biochemistry. It also includes an investigation of the traditional pillars of medicine (anatomy, physiology, biochemistry, pathology and pharmacology) integrated in the context of each of the major systems relevant to the human body. Cross-referenced to the Oxford Handbook of Clinical Medicine, and thoroughly illustrated, it is the ideal introduction to the medical sciences for medical students and biomedical scientists, as well as a valuable refresher for junior doctors.